Cell-Assisted Lipotransfer Breast Restoration
Joel Aronowitz, MD, is the surgeon who performed the groundbreaking Cell-Assisted Lipotransfer procedure on Suzanne Somers. In this exclusive interview, Dr. Aronowitz discusses the scientific intricacies of this procedure with Life Extension research scientist Greg Fahy, PhD.
Cancer Establishment Hides Radiation Side Effects
The long-term side effects of cancer radiation therapy are revealed, along with documented methods to mitigate them.
Consumers Do Crave Healthy Foods!
A year ago Life Extension® posed the question, "Do consumers really want healthy foods?" The answer was a resounding Yes! Even though these cruciferous vegetable recipes cost more than glucose-spiking commercial soups, initial sales were six times greater than projected. Here we offer the rationale behind our pain-staking efforts to make recently improved versions of Cruciferous Vegetable and Asian Cruciferous Vegetable soups.
Link Between Alcohol and Cancer Death
A 2011 European study found that alcohol intake accounted for one in ten cancer cases for men and one in thirty for women, even in moderate amounts. The reason? Alcohol is metabolized by the body into a DNA-mutating compound called acetaldehyde. Fortunately, a number of nutrients have been shown to neutralize acetaldehyde, ideally taken before you drink or before going to sleep if excessive alcohol is consumed.
CR Way™ Success Stories
From a top New York executive to a surgeon in Birmingham, England, members of LivingTheCRWay are proving that calorie restriction can result in remarkable and rapid improvements in overall health. Using CR regimens suited to their specific needs and temperaments, one woman lost 100 lbs in 18 months, while an aging man completely reversed his osteoarthritis.
Outrageous FDA Delay Endangers Melanoma Victims
Melanoma is almost completely curable if caught in time, yet 30% of malignant lesions go undetected due to human error. With a 98% accuracy rate, you would think a breakthrough, non-invasive diagnostic device called MelaFind® would gain swift FDA approval. In this exposé, we reveal why this technology languished in limbo for years—and how stifling agency bias and negligence are sending similar innovations overseas.